Cardiac Involvement in Miscellaneous Systemic Diseases

The heart may be involved in a number of systemic syndromes. Many of these have been mentioned briefly in prior subsections of this chapter. The pericardium, myocardium, heart valves, and coronary arteries may be involved either singly or in various combinations. In most cases the cardiac manifestations are not the dominant feature, but in some it is the primary cause of symptoms and may be fatal.

The most common type of myocardial involvement is an infiltrative cardiomyopathy, such as systemic amyloidosis, sarcoidosis, hemochromatosis, or glycogen storage disease. Cardiac calcinosis can occur in hyperparathyroidism (usually the secondary form) and in primary oxalosis. A number of muscular dystrophies can cause a cardiomyopathic picture (particularly Duchenne’s, less frequently myotonic dystrophy, and several rarer forms).

In addition to left ventricular dysfunction and heart failure, all of these conditions frequently cause conduction abnormalities, which may be the presenting or only feature.

The myocardium may also be involved in inflammatory and autoimmune diseases. It is commonly affected in polymyositis and dermatomyositis, but usually this is subclinical. Systemic lupus erythematosus, scleroderma, and mixed connective tissue disease may cause myocarditis, but these commonly also involve the pericardium, coronary arteries, or valves. Several endocrinopathies, including acromegaly, thyrotoxicosis, myxedema, and pheochromocytoma, can produce cardiomyopathies, though again they are usually not isolated features.

Pericardial involvement is quite common in many of the connective tissue diseases. Systemic lupus erythematosus may present with pericarditis, and pericardial involvement is not uncommon (but is less frequently symptomatic) in active rheumatoid arthritis, systemic sclerosis, and mixed connective tissue disease. Endocardial involvement takes the form of patchy fibrous - predominantly on the right side - or inflammatory or sclerotic changes of the heart valves. Carcinoid heart disease typically is manifested as Tricuspid regurgitation, and the same may be the case in systemic lupus erythematosus. The hypereosinophilic syndromes involve the endocardium, leading to restrictive cardiomyopathy. A variety of arthritic syndromes are associated with aortic valvulitis or aortitis, including ankylosing spondylitis, rheumatoid arthritis, and Reiter’s syndrome, as is tertiary syphilis also. Disorders of elastic tissue (Marfan’s syndrome is the most frequent) often affect the ascending aorta, with resulting Aneurysmal dilation and aortic regurgitation.

Almost any vasculitic syndrome can involve the coronary arteries, leading to myocardial infarction. This is most common with polyarteritis nodosa and systemic lupus erythematosus. Two vasculitic syndromes have a particular predilection for the coronary arteries - Kawasaki’s disease and Takayasu’s disease. In these, myocardial infarction may be the presenting symptom.

Biondi M: Effects of subclinical thyroid dysfunction on the heart. Ann Intern Med 2002;137:904.

Kulke MH et al: Carcinoid tumors. N Engl J Med 1999;340:858.

Moder KG et al: Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 1999;74:275.

Riboldi P et al: Cardiac involvement in systemic autoimmune diseases. Clin Rev Allergy Immunol 2002;23:247.

Wijetunga M et al: Myocarditis in systemic lupus erythematosus. Am J Med 2002;113:419.

RELATED STORIES:
Cardiovascular Screening of Athletes   The Cardiac Patient & Pregnancy   Cardiovascular Complications of Pregnancy   The Cardiac Patient & Surgery   Traumatic Heart Disease   Pulmonary Heart Disease (Cor Pulmonale)   Neoplastic Diseases of the Heart   Constrictive Pericarditis   Primary Pulmonary Hypertension   Pericardial Effusion   Acute Pericarditis   Rheumatic Heart Disease

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]